The maker of EpiPen that is accused of gouging prices on their product has turned out to have close ties to Hillary Clinton and the Clinton Foundation. And the sun rises in the East. Mylan, the company that makes the EpiPen, which is used to stop fatal allergic reactions has seen an increase in prices from $57 dollars in 2007 to $609 today. Hillary described Mylan as gouging on their prices. It makes for a good sound bite, but Mylan has contributed up to $250,000 to the Clinton Foundation and even partnered with them on drugs for Aids patients.
The lamestream media has made a big deal about CEO, Heather Bresch’s pay increasing from 2.4 million in 2007 to over 18.9 million today. What none of the talking heads have mentioned is that she has very close ties to a democratic Senator that is a big Hillary booster. Sen Joe Manchin of West Virginia is her father. Another thing they failed to mention is that while claiming the gouging began in 2007 during the Bush administration, the cost of the EpiPen rose sharply beginning in 2011 just as they began working with the Clinton Foundation. In 2011 the EpiPen sold for $157,in 2014 it rose to $360, in 2015 the price rose to $461 and in 2016 rose to $619.
That means in six years the price of the EpiPen nearly quadrupled. Although in direct contributions to the Clinton Foundation, Mylan has made payment of between 100 and 250k, they have also aided them indirectly. The Clinton Foundation says that it supplies more Aids medicines around the world than anyone. Mylan lowered their price on Aids medicine to $425 a year, which is a full 28% lower than their competition. If the Foundation distributes as much of these drugs as they claim, that would amount to a lot of money. Mylan would also benefit by increasing their market share.